Results 291 to 300 of about 164,269 (359)
Abstract Objective To assess the association between obstructive sleep apnea (OSA) risk levels and major cardiovascular disease (CVD) subtypes in individuals with metabolic dysfunction‐associated fatty liver disease (MAFLD). Methods This cohort study included 128,022 MAFLD participants from the UK Biobank without CVD at baseline.
Haizhen Chen +4 more
wiley +1 more source
FGF1 ameliorates hepatic steatosis through acute activation of the unfolded protein response and VLDL production. [PDF]
van Zutphen T +10 more
europepmc +1 more source
New insights into lipid droplet breakdown in alcohol-associated hepatic steatosis. [PDF]
Zhang C, Ding WX.
europepmc +1 more source
Serum LEAP-2 as a Potential Biomarker for Hepatic Steatosis in Adolescents with Obesity and MASLD: A Cross-Sectional Study. [PDF]
Çakar S +7 more
europepmc +1 more source
Hepatic steatosis index as an independent predictor of hypertension in patients with type 2 diabetes: a cross-sectional study. [PDF]
Ma X +6 more
europepmc +1 more source
Focal hepatic steatosis as a rare complication of microwave ablation-induced portal vein thrombosis: A radiologic case report. [PDF]
Akbas B +7 more
europepmc +1 more source
Correction to "Catalpol Attenuates Hepatic Steatosis by Regulating Lipid Metabolism via AMP-Activated Protein Kinase Activation". [PDF]
europepmc +1 more source

